The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Tarsus Pharmaceuticals Inc shares valued at $286,924 were sold by Farrow Jeffrey S on Jun 18 ’24. At $27.47 per share, Farrow Jeffrey S sold 10,445 shares. The insider’s holdings dropped to 18,136 shares worth approximately $0.44 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Azamian Bobak R. sold 10,415 shares, netting a total of over 318,699 in proceeds. Following the sale of shares at $30.60 each, the insider now holds 26,456 shares.
Before that, Neervannan Seshadri had sold 4,879 shares from its account. In a trade valued at $149,297, the Chief Operating Officer traded Tarsus Pharmaceuticals Inc shares for $30.60 each. Upon closing the transaction, the insider’s holdings decreased to 4,879 shares, worth approximately $1.57 million.
As published in their initiating research note from Goldman on November 20, 2023, Tarsus Pharmaceuticals Inc [TARS] has been a Neutral and the price target has been revised to $19. Analysts at William Blair started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid July. As of May 18, 2023, Guggenheim has initiated its “Buy” rating for TARS. Earlier on August 01, 2022, Barclays initiated its rating. Their recommendation was “an Overweight” for TARS stock.
Analyzing TARS Stock Performance
During the last five days, there has been a drop of approximately -14.02%. Over the course of the year, Tarsus Pharmaceuticals Inc shares have jumped approximately 19.95%. Shares of the company reached a 52-week high of $42.50 on 05/09/24 and a 52-week low of $18.99 on 01/05/24. A 50-day SMA is recorded $29.77, while a 200-day SMA reached $27.07. Nevertheless, trading volume fell to 0.56 million shares from 1.01 million shares the previous day.
Support And Resistance Levels for Tarsus Pharmaceuticals Inc (TARS)
According to the 24-hour chart, there is a support level at 23.57, which, if violated, would cause prices to drop to 22.85. In the upper region, resistance lies at 25.02. The next price resistance is at 25.74. RSI (Relative Strength Index) is 33.13 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.71, which suggests the price will decrease in the coming days. Percent R is at 90.74%, indicating bearish price movement. Stochastics%K at buying indicates that the stock is to be held.
Which companies own the most shares of Tarsus Pharmaceuticals Inc (TARS)?
On December 21, 2021, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $40.
